Generic Ambien CR

The insomnia drug Ambien CR is currently available in both brand-name and generic form. The generic versions are sold in two strengths (6.25 mg and 12.5 mg) and are made by Actavis Elizabeth, LLC, and Anchen, Inc. The FDA has given these products an "AB" rating, which means they are considered equivalent to brand-name Ambien CR.

Can I Buy Generic Ambien CR?

Ambien CR™ (zolpidem tartrate extended-release tablets) is a medication that is used to treat insomnia in adults. Brand-name Ambien CR is manufactured by sanofi-aventis. However, the medication is also available in generic form.

Availability of Generic Ambien CR

At this time, generic Ambien CR is available in the following strengths:
  • Zolpidem ER 6.25 mg
  • Zolpidem ER 12.5 mg.
It is made by various generic manufacturers, such as:
  • Actavis Elizabeth, LLC
  • Anchen, Inc.
  • Winthrop US.

Is the Generic Version as Good as Ambien CR?

All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. The generic versions of Ambien CR have an "AB" rating, which means they should be equivalent to Ambien CR.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.

Information on Ambien CR

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.